Why low-cost ketamine is still inaccessible to many with severe depression
A case study on ketamine reveals systemic barriers that prevent repurposing existing low-cost drugs like ketamine for treatment-resistant depression.
Oct 23, 2023
0
0
A case study on ketamine reveals systemic barriers that prevent repurposing existing low-cost drugs like ketamine for treatment-resistant depression.
Oct 23, 2023
0
0
A therapy session with Patricia Brown starts like any other. She leads her clients into a peaceful, quiet room, draped in beige and generic, calming artwork.
Oct 17, 2023
1
1
It can be challenging to create a treatment plan for depression. This is especially true for patients who aren't responding to conventional treatments and are undergoing experimental therapies such as deep brain stimulation. ...
Sep 21, 2023
0
4
A team of leading clinicians, engineers, and neuroscientists has made a groundbreaking discovery in the field of treatment-resistant depression. By analyzing the brain activity of patients undergoing deep brain stimulation ...
Sep 20, 2023
0
15
Ketamine can be used to manage treatment-resistant depression but researchers warn it should be done so sparingly.
Aug 25, 2023
0
14
Depression has been on the rise in recent years. According to a study in the American Journal of Preventive Medicine, nearly one in 10 adults and one in five adolescents reported having depression in 2020, up from 6.6% of ...
Jul 17, 2023
0
2
Ketamine might be better known as a recreational drug or anesthetic. But there's growing evidence for its use for people with hard-to-treat depression.
Jul 14, 2023
0
2
A low-cost version of ketamine to treat severe depression has performed strongly in a double-blind trial that compared it with placebo.
Jul 13, 2023
0
1
Psychedelics stand at a pivotal crossroad in mental health, offering the prospect of novel therapeutic avenues to address multiple mental conditions, from treatment-resistant depression to post-traumatic stress disorder (PTSD). ...
Jun 16, 2023
0
93
A new study led by investigators from Mass General Brigham has found that subanesthetic intravenous ketamine was effective and not inferior to electroconvulsive therapy (ECT) for the treatment of non-psychotic, treatment-resistant ...
May 24, 2023
0
105